Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 185 of 1,261
  1. US 11693015

    Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function

    Maximus Diagnostic Technologies LLC · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  2. US 11692184

    Thermostable RNA-guided endonucleases and methods of use thereof

    The Regents of the University of California · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  3. US 11690894

    Transgenic corn with antifungal peptide AGM182 (DN:0113.18)

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  4. US 11690853

    Non-hormonal steroid modulators of NF-κβ for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  5. US 11690837

    Methods of improving cell-based therapy

    The Regents of the University of California · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  6. US 11690825

    20-HETE receptor (GPR75) antagonists and methods of use

    The Board of Regents of the University of Texas System · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  7. US 11690850

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  8. US 11691987

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  9. US 11690919

    Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells

    The Board of Regents of the University of Texas System · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  10. US 11690901

    Southern cattle tick vaccine product

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  11. US 11690895

    Compositions and methods of interferon alpha binding proteins

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  12. US 11690827

    Methods for treating ocular Demodex using lotilaner formulations

    Tarsus Pharmaceuticals, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  13. WO 2023118563

    THÉRAPIE POUR MODULER UNE RÉPONSE IMMUNITAIRE AU MOYEN D'UN MVA RECOMBINANT CODANT POUR IL-12

    BAVARIAN NORDIC AS [DK] · Granted Jun 29, 2023 · Expires Jun 24, 2043

    granted
  14. WO 2023118508

    VIRUS MVA RECOMBINANTS POUR ADMINISTRATION INTRAPÉRITONÉALE POUR LE TRAITEMENT DU CANCER

    BAVARIAN NORDIC AS [DK] · Granted Jun 29, 2023 · Expires Jun 24, 2043

    granted
  15. US 2023203129

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    BRACCO IMAGING SPA [IT] · Granted Jun 29, 2023 · Expires Jun 24, 2043

    granted
  16. US 11684609

    Compounds and methods for treating an epileptic disorder

    The Regents of the University of California · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  17. US 11685921

    Molecules and agents for treating hepatitis B virus

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  18. US 11684572

    Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses

    United Kingdom Research and Innovation · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  19. US 11685906

    Compositions and methods for treating ornithine transcarbamylase deficiency

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  20. US 11684570

    Pharmaceutical ophthalmic compositions

    EYE CARE NORTHWEST, PA · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  21. US 11685918

    Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  22. US 11685784

    Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same

    China Medical University Hospital · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  23. US 11684797

    Laser assisted wound healing protocol and system

    THE BIOREGENTECH INSTITUTE, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  24. US 11685750

    Crystalline forms of IRAK degraders

    Kymera Therapeutics, Inc. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.